EULAV Asset Management’s Guardant Health GH Stock Holding History

EULAV Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-54,000	Closed	-$1.6M	–	179
2023 Q3	$1.6M	Hold	54,000	–	–	0.06%	178
2023 Q2	$1.93M	Sell	54,000 -6,000	-10%	-$172K	0.07%	173
2023 Q1	$1.41M	Sell	60,000 -15,000	-20%	-$428K	0.06%	185
2022 Q4	$2.04M	Buy	+75,000	New	+$3.43M	0.09%	167

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EULAV Asset Management's GH Position: Q4 2023 in Review

EULAV Asset Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 54,000 shares — an estimated $1.6M sold.

EULAV Asset Management first reported a position in GH in Q4 2022 and held it in 4 quarters. The position peaked at $2.04M in Q4 2022. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

EULAV Asset Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
EULAV Asset Management sold 54,000 Guardant Health shares in Q4 2023, an estimated $1.6M.
EULAV Asset Management first reported a position in Guardant Health in Q4 2022 and held it in 4 quarters.
EULAV Asset Management's Guardant Health position peaked at $2.04M in Q4 2022.
295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on EULAV Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.